Clinical Trials Browser

Phase 1/2 × Leukemia, B-Cell × Lenalidomide × Clear all

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell